# Bectas Therapeutics, Inc. — Form D/A

Bectas Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2025-10-08. The offering totals $10.0M, of which $5.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-10-08
- Form: D/A
- Accession: 0002038826-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.5M
- Remaining: $4.5M
- Investors: 13
- Date of first sale: 2022-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526249

## Issuer

- Name: Bectas Therapeutics, Inc.
- CIK: 0002038826
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3262 WESTHEIMER ROAD, HOUSTON, TX, 77098
- Phone: 617-834-3476

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Lynda Chin | Director | Houston, TX |
| Ronan O'Hagan | Director | Houston, TX |
| Jon A Brilliant | Executive Officer | Houston, TX |
| Ronan O'Hagan | Executive Officer | Houston, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-10-09](https://search.stillhousedata.com/formd/0002038826-24-000001) | D | $10.0M | $4.2M |

## More

- [CIK 2038826 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2038826&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002038826-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.